Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation and Warrants

v3.10.0.1
Stock-Based Compensation and Warrants
3 Months Ended
Sep. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share Based Compensation [Text Block]
Note 8 Stock-Based
Compensation and Warrants
 
Options
 
During the quarter ended September 30, 2018, the Company granted 1,125,000 options to employees and 1,702,767 options were forfeited. The Company has 
computed the fair value of all options granted using the Black-Scholes option pricing model. Options that require specific events before they begin to vest are valued at the grant date, however; have not been recorded as the specific event is not probable of occurring. In order to calculate the fair value of the options, certain assumptions are made regarding components of the model, including the estimated fair value of the underlying common stock, risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to valuation. The Company estimated a volatility factor utilizing comparable published volatility of several peer companies. Due to the small number of option holders, the Company has estimated a forfeiture rate of zero as the value of each option holder is calculated individually. The Company estimates the expected term based on the average of the vesting term and the contractual term of the options. The risk-free interest rate is based on the U.S. Treasury yield in effect at the time of the grant for treasury securities of similar maturity.
 
Rezolute has computed the fair value of all options granted during the three months ended September 30, 2018 using the following assumptions:
 
Expected volatility
 
 
84
%
Risk free interest rate
 
 
2.83
%
Expected term (years)
 
 
7.0
 
Dividend yield
 
 
0
%
 
Stock option activity is as follows:
 
 
 
 
 
 
Weighted
 
 
Weighted Average
 
 
 
Number of
 
 
Average
 
 
Remaining
 
 
 
Options
 
 
Exercise Price
 
 
Contractual Life
 
Outstanding, June 30, 2018
 
 
19,415,246
 
 
$
1.55
 
 
 
7.8
 
Granted
 
 
1,125,000
 
 
$
0.52
 
 
 
 
 
Forfeited
 
 
(1,702,767
)
 
$
1.62
 
 
 
 
 
Outstanding, September 30, 2018
 
 
18,837,479
 
 
$
1.65
 
 
 
7.7
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exercisable at September 30, 2018
 
 
10,901,335
 
 
$
1.89
 
 
 
6.3
 
 
Stock-based compensation expense related to the fair value of stock options was included in the statement of operations as research and development – compensation and benefits expense of $129,609 and $298,955 and as general and administrative – compensation and benefits expense of $748,342 and $1,208,744 for the three months ended September 30, 2018 and 2017, respectively. The unrecognized stock-based compensation expense at September 30, 2018 is $3,994,793. The Company expenses the fair value of stock comparison ratably over the vesting period.
 
Warrants
-
The Company issued warrants to agents in conjunction with the closing of various financings and issued warrants in private placements as follows:
 
 
 
 
 
 
Weighted
 
 
Weighted Average
 
 
 
Number of
 
 
Average
 
 
Remaining
 
 
 
Warrants
 
 
Exercise Price
 
 
Contractual Life
 
Outstanding, June 30, 2018
 
 
45,635,217
 
 
$
1.37
 
 
 
3.40
 
Warrants issued for consulting services
 
 
15,624
 
 
$
1.00
 
 
 
 
 
Warrants expired
 
 
-
 
 
$
-
 
 
 
 
 
Outstanding, September 30, 2018
 
 
45,650,841
 
 
$
1.37
 
 
 
3.09
 
 
For the Three Months Ended September 30, 2018:
The Company issued warrants to purchase 15,624 shares of common stock at a price of $1.00 in connection with a consulting agreement.